investigating pp2a-based therapeutic strategies for kmt2a-rearranged acute leukemia
Published 5 months ago • 109 plays • Length 8:40Download video MP4
Download video MP3
Similar videos
-
0:57
novel therapeutic strategies in all
-
1:05
reprogramming leukemia cells into apcs as a novel therapeutic strategy for b-all
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
3:52
maintenance therapy with revumenib following allosct in kmt2ar and npm1-mutated acute leukemias
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
2:06
introducing molecular diagnostics to improve leukemia care in developing countries
-
1:05
personalized therapy in leukemia: a case study
-
1:18
the talisman study: prophylactic treatment for talquetamab-related oral toxicity in myeloma
-
1:36:39
mpn connect - dose optimization jakavi for treatment of mf | essential thrombocythemia: prognostic &
-
1:06:04
itp: novel treatments
-
1:46:07
hematology lecture
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma
-
2:45
an insight into clinical risk factors for progression in mpns
-
6:03
genomics and acute leukemia management: artificial intelligence, deep learning & pre-leukemic clones
-
15:15
utilization of multimodality testing data to develop optimal diagnostic algorithm for ped. leukemia
-
2:41
an overview of the latest advances in hematology
-
3:48
trials of interest in newly diagnosed myeloma presented at ims 2024
-
1:43
the importance of understanding cellular functionality to develop biological therapies for cll
-
2:43
diagnostic tools for aml
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf